sorbitol has been researched along with rifampin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kozhina, T; Stateva, L; Venkov, P | 1 |
| Goulian, M; Goulian, SH; Ramareddy, GV | 1 |
| Bisset, J; Flint, HJ; Webb, J | 1 |
| Battaner, E; Hadjiolov, AA; Schlessinger, D; Venkov, PV | 1 |
| Agatonovic-Kustrin, S; Glass, BD; Wisch, MH | 1 |
| Bachleda, P; Dvorák, Z; Vrzal, R | 1 |
1 review(s) available for sorbitol and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for sorbitol and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Genetic analysis of an osmotic sensitive Saccharomyces cerevisiae mutant.
Topics: Genes, Recessive; Genetic Linkage; Mutation; Osmosis; Rifampin; Saccharomyces cerevisiae; Sorbitol | 1979 |
DNA synthesis in vitro in lysates of Escherichia coli.
Topics: Binding Sites; DNA Nucleotidyltransferases; DNA, Bacterial; Escherichia coli; Kinetics; Molecular Weight; Mutation; Phenotype; Rifampin; RNA, Bacterial; Sorbitol; Species Specificity; Templates, Genetic | 1975 |
Use of antibiotic resistance mutations to track strains of obligately anaerobic bacteria introduced into the rumen of sheep.
Topics: Animals; Bacteroidaceae; Bacteroides; Drug Resistance, Microbial; Mutation; Rifampin; Rumen; Sheep; Sorbitol | 1989 |
Saccharomyces cerevisiae: sorbitol-dependent fragile mutants.
Topics: Cell Division; Cell Survival; Centrifugation, Zonal; Cycloheximide; Mutation; Rifampin; RNA; Saccharomyces cerevisiae; Sorbitol; Spectrophotometry; Spectrophotometry, Ultraviolet; Temperature; Time Factors; Tritium; Uracil | 1974 |
Artificial neural networks to optimize formulation components of a fixed-dose combination of rifampicin, isoniazid and pyrazinamide in a microemulsion.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Caprylates; Chemistry, Pharmaceutical; Child; Drug Combinations; Drug Stability; Emulsions; Humans; Isoniazid; Neural Networks, Computer; Polyethylene Glycols; Polysorbates; Pyrazinamide; Rifampin; Solubility; Sorbitol; Triglycerides | 2005 |
Activation of MAPKs influences the expression of drug-metabolizing enzymes in primary human hepatocytes.
Topics: Anisomycin; Aryl Hydrocarbon Hydroxylases; Dioxins; Enzyme Activation; Enzyme Activators; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Glucuronosyltransferase; Glutathione Transferase; Hepatocytes; Humans; Phenobarbital; Rifampin; RNA, Messenger; Sorbitol; Sulfotransferases | 2009 |